Kazakh ThromboTest for intraoperative thrombosis risk assessment during stent-assisted cerebral aneurysm treatment: a single-center clinical study
The Kazakh ThromboTest represents a practical and cost-effective intraoperative method with a high negative predictive value for identifying acute thrombotic risk during stent-assisted aneurysm repair. Despite adequate VerifyNow<sup>™</sup> testing, KTT enabled timely procedural modifications, particularly in settings where standard platelet function assays are either unreliable or inaccessible. While VerifyNow<sup>™</sup> did not predict thrombotic events, KTT contributed to safer procedural management and may serve as a valuable adjunct in neurointerventional practice.
Authors
- Aiman Maidan (ORCID: https://orcid.org/0000-0003-3321-9714)
- Mynzhylky Berdikhojayev (ORCID: https://orcid.org/0000-0003-1260-5923)
- Roger Barranco (ORCID: https://orcid.org/0000-0001-5491-2687)
- Shayakhmet Makhanbetkhan (ORCID: https://orcid.org/0000-0003-2606-4785)
- Marat Sarshayev (ORCID: https://orcid.org/0000-0003-1757-9189)
- Dimash Davletov (ORCID: https://orcid.org/0009-0006-6100-4963)
- Rajeev Sivasankar
- Maxat Mussabekov
Institutions
- Kazakh National Medical University (KZ)
- National Nuclear Center of the Republic of Kazakhstan (KZ)
- Instituto Cardiovascular de Rosario (AR)
- Fortis Hospital (IN)
Publication Details
- Journal
- Frontiers in Neurology
- Published
- 2025-11-04
- DOI
- https://doi.org/10.3389/fneur.2025.1687591
- Primary Topic
- Antiplatelet Therapy and Cardiovascular Diseases
- Type
- article
- Field-Weighted Citation Impact
- 0.00